The Cancer Research Trust (CRT) is pleased to advise that the Memorandum of Understanding (MOU) between the Australian Cancer Research Foundation (ACRF) and the CRT, originally signed in July 2019 and extended for the period 2022 – 2024, has once again been extended for a further three years until the end of 2028. The MOU […]
Australian Cancer Research Foundation (ACRF) Co-funding MOU Renewed 2025 – 2028 Read More »
The CRT Board is delighted to welcome a new Board member, Dr Helga Mikkelsen. Dr Helga Mikkelsen is WA-based Investment Manager at Brandon Capital, which is Australia and New Zealand’s largest large life science-focused venture capital firm. Following degrees in Chemical Engineering and Biotechnology, Helga completed her PhD in microbiology at the University of Cambridge
CRT Welcomes A New Board Member Read More »
The CRT congratulates Dr Ben Dwyer, Scientific Lead in the CRT funded “Defeating Primary Liver Cancer” program and Project Lead on the CRT funded “Australian Centre for RNA Therapeutics in Cancer” (ACRTC) program, on being awarded more than $500,000 from the WA Government’s Future Health Research and Innovation (FHRI) Fund. The funds will contribute to
Ben Dwyer Successfully Awarded a $0.5m Grant from the FHRIF to Set up an Organoid Hub Read More »
![[L to R] Prof Anna Nowak, DVC-R (UWA), Prof Jonas Nilsson, Prof Archa Fox, The Hon Stephen Dawson, Minister for Medical Research & Peter Mansell, Chairman CRT](https://www.cancerresearchtrust.org.au/wp-content/uploads/2023/11/2023.11.03-Collaborative-2023-93-1500x1000px-1024x683.jpg)
The Cancer Research Trust (CRT) is very pleased to announce that the successful applicants for the 2023 CRT WA Collaborative Cancer Research Grants are: Professor Archa Fox, Chief Investigator, for her “Australian Centre for RNA Therapeutics in Cancer” program Professor Jonas Nilsson and Associate Professor Elin Gray, Co-Chief Investigators of their “Establishing TIL Therapy for
UWA’s Leading Cancer Researchers Awarded $15.5m Read More »
The Collaborative Cancer Grant Scheme (CCGS) was developed by the Cancer Council WA in 2016 as a new funding initiative and has, in partnership with leading Western Australian institutions, awarded $1,121,471 to successful recipients over four funding rounds. The CRT is proud to have contributed to the Collaborative Cancer Grant Scheme in 2021. In 2021, this
Building Capacity and Innovation in WA’s Cancer Research Community Read More »
Submission of EOI closes on Wednesday 30 November 2022. The Cancer Research Trust (CRT) has established The Grant to support, energise and fund collaborative and innovative cancer research in Western Australia. The Grant will provide support for teams of high calibre researchers to pursue broad based, multi-disciplinary cancer activities, to increase the inter-institutional collaboration of
On 1 July 2019, a Memorandum of Understanding (MOU) between the Australian Cancer Research Foundation (ACRF) and the Cancer Research Trust (CRT) was signed, setting forth the terms and understanding to further enhance cancer research capacity in Western Australia and increase the coordination by cancer research funders. This cooperation is in the form of the
Australian Cancer Research Foundation (ACRF) MOU Renewed Read More »
The Cancer Research Trust is very pleased to announce that, following a very favourable review by a panel of internationally renowned cancer researchers of the first five years of Professor Alistair Forrest’s “Enabling Advance Single Cell Cancer Genomics in WA” project, the CRT WA Collaborative Cancer Research Grant funding of this project first awarded in
The Cancer Research Trust (CRT) is very pleased to announce that the successful applicants for the 2020 CRT WA Collaborative Cancer Research Grant are Professor Peter Leedman and Associate Professor Nina Tirnitz-Parker, Co-Chief Investigators of their “Defeating Primary Live Cancer” application. Further information can be found on the project summary page and in the following
Boost For Liver Cancer Patients With New $10.8 Million World-Class Research Centre Read More »
The CRT Board is delighted to welcome two new Board members viz. Professor Ruth Ganss and Dr Joost Lesterhuis. Professor Ruth Ganss is the Scientific Head of the Cancer Division at the Harry Perkins Institute of Medical Research. Her current research activities focus on translational anti-cancer aspects of stromal remodelling and immunotherapy.Read more >> Dr
CRT Welcomes Two New Board Members Read More »
